| Host: |
Rabbit |
| Applications: |
IHC/IF/ELISA |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Protein S100-A11 (30-110 aa) is suitable for use in Immunohistochemistry, Immunofluorescence and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
IHC 1:100-1:300ELISA 1:10000IF 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
S100A11 |
| Gene ID: |
6282 |
| Uniprot ID: |
S10AB_HUMAN |
| Immunogen Region: |
30-110 aa |
| Specificity: |
Calgizzarin Polyclonal Antibody detects endogenous levels of Calgizzarin protein. |
| Immunogen: |
Synthesized peptide derived from Calgizzarin at the amino acid range 30-110 |
| Function | Facilitates the differentiation and the cornification of keratinocytes. |
| Protein Name | Protein S100-A11CalgizzarinMetastatic Lymph Node Gene 70 ProteinMln 70Protein S100-CS100 Calcium-Binding Protein A11 Cleaved Into - Protein S100-A11 - N-Terminally Processed |
| Database Links | Reactome: R-HSA-6798695 |
| Cellular Localisation | CytoplasmNucleus |
| Alternative Antibody Names | Anti-Protein S100-A11 antibodyAnti-Calgizzarin antibodyAnti-Metastatic Lymph Node Gene 70 Protein antibodyAnti-Mln 70 antibodyAnti-Protein S100-C antibodyAnti-S100 Calcium-Binding Protein A11 Cleaved Into - Protein S100-A11 - N-Terminally Processed antibodyAnti-S100A11 antibodyAnti-MLN70 antibodyAnti-S100C antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
